Author:
Lucas Gregory M.,Griswold Michael,Gebo Kelly A.,Keruly Jeanne,Chaisson Richard E.,Moore Richard D.
Publisher
Oxford University Press (OUP)
Reference49 articles.
1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2002 ed, vol 14, table 16. (Available at http://www.cdc.gov/hiv/stats/hasrlink.htm). (Last accessed December 2004).
2. UNAIDS. AIDS epidemic update: December 2005. (Available at http://www.unaids.org/Epi2005/doc/report_pdf.html). (Last accessed December 2005).
3. Celentano DD, Galai N, Sethi AK, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS2001;15:1707–15.
4. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA1998;280:547–9.
5. Murri R, Fantoni M, Del Borgo C, et al. Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. J Acquir Immune Defic Syndr1999;22:461–6.
Cited by
155 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献